Compass Therapeutics Inc.
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| – | -53.0% | +70.9% | +196.2% | +29.8% | -21.4% | -10.5% | +56.4% | |
| – | -55.4% | +91.3% | +193.0% | +32.4% | -21.0% | -13.7% | +58.1% | |
| – | -56.0% | +86.0% | +207.0% | -75.8% | -30.7% | +79.5% | -29.5% | |
| – | -56.0% | +86.0% | +207.0% | +29.1% | -18.3% | -16.9% | +64.9% | |
| – | – | – | – | – | – | – | – | |
| – | -30.1% | -70.0% | +462.3% | -75.3% | – | – | – | |
| – | -0.3% | -92.0% | +14.3% | +31.6% | -53.7% | +82.0% | +50.3% | |
| – | +16.0% | +2.8% | +5.3% | +52.1% | -51.8% | +13.8% | +57.4% | |
| – | +51.2% | +33.9% | -86.8% | +10.9% | +9.1% | -71.8% | +195.9% | |
| – | -63.6% | +68.7% | -18.3% | +290.1% | +20.9% | -45.0% | -29.5% | |
| – | -16.0% | -79.9% | – | – | – | – | – | |
| – | – | – | +250.7% | +29.7% | -18.2% | -15.7% | +57.1% | |
| – | – | – | – | – | – | – | – | |
| – | +942.2% | +7.9% | +11.8% | +67.3% | +20.8% | +7.9% | +15.0% |
Data as of: September 18, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.